M
Margaux Kosim
Publications - 3
Citations - 34
Margaux Kosim is an academic researcher. The author has contributed to research in topics: Buprenorphine & Addiction medicine. The author has an hindex of 2, co-authored 3 publications receiving 20 citations.
Papers
More filters
Journal ArticleDOI
What place for prolonged-release buprenorphine depot-formulation Buvidal® in the treatment arsenal of opioid dependence? Insights from the French experience on buprenorphine.
Florence Vorspan,Peter Hjelmström,Nicolas Simon,Amine Benyamina,Alain Dervaux,Georges Brousse,Thierry Jamain,Margaux Kosim,Benjamin Rolland +8 more
TL;DR: Buvidal® could constitute a promising treatment option mainly in case of: 1) OMT initiation, including in non-specialized addiction medicine care; 2) Discharge from prison or hospital; Diversion/misuse of 3) buprenorphine or 4) methadone; 5) Clinically stabilized patients wishing to avoid daily oral taking of the medication.
Journal ArticleDOI
Determinants of interest in extended-released buprenorphine: A survey among 366 French patients treated with buprenorphine or methadone.
Benjamin Rolland,Benoit Trojak,Mikail Nourredine,Jérôme Bachellier,Mathieu Chappuy,Patrick Bendimerad,Margaux Kosim,Peter Hjelmström,Fadi Meroueh,Philippe Nubukpo,Georges Brousse +10 more
TL;DR: In this article, the authors explored the factors determining the interest in extended-release buprenorphine (XR-BUP) injections among patients receiving opioid agonist treatment (OAT) in France.
Journal ArticleDOI
Factors of Interest in Extended-Release Buprenorphine: Comparisons Between Incarcerated and Non-Incarcerated Patients with Opioid Use Disorder.
Mathieu Chappuy,Fadi Meroueh,Benoit Trojak,Jérôme Bachellier,Patrick Bendimerad,Margaux Kosim,Peter Hjelmström,Philippe Nubukpo,Georges Brousse,Benjamin Rolland +9 more
TL;DR: In this paper, the reasons of interest in XR-BUP were compared between incarcerated and non-incarcerated interviewees, using logistic regressions models, which provided raw and adjusted odds ratios (aORs) and 95% confidence intervals (95% CI).